glp 1 pcos The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome It can Take up to

In simplified terms: BPC-157 Enhanced VEGFR2 signalling PI3K activation Akt activation eNOS phosphorylation Increased NO production This increased nitric oxide production leads to: Relaxation of vascular smooth muscle Arterial dilation Increased tissue perfusion Why This Matters Improved blood flow means: More oxygen delivery More nutrient transport Faster waste removal Better inflammatory resolution In injury models, increased perfusion strongly correlates with improved healing rates

Funding This study was supported by National Natural Science Foundation of China (No.81901186, No.82171458, No.82101374, and No.81974188)

The mechanism is sound, the evidence base is adequate, and the safety profile is excellent

Purity:Greater than 98.0% as determined by SDS-PAGE

Only about 4% of people in studies needed to stop the medication because of their GI symptoms, which suggests that with the right support, relief is possible

Neuropharmacology 135, 368375